Scarica l'app Stockscreener
1.02
9.73%
-0.11
Dopo l'orario di chiusura:
1.02
Precedente Chiudi:
$1.13
Aprire:
$1.12
Volume 24 ore:
1.30M
Relative Volume:
2.10
Capitalizzazione di mercato:
$15.38M
Reddito:
-
Utile/perdita netta:
$-11.90M
Rapporto P/E:
-0.00495
EPS:
-206.0125
Flusso di cassa netto:
$-12.75M
1 W Prestazione:
+2.00%
1M Prestazione:
-2.86%
6M Prestazione:
-25.00%
1 anno Prestazione:
+470.79%
Intervallo 1D:
$0.9774
$1.13
Intervallo di 1 settimana:
$0.945
$1.14
Portata 52W:
$0.1131
$3.95
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Nome
Allarity Therapeutics Inc
Settore
Industria
Telefono
401-426-4664
Indirizzo
24 SCHOOL ST., 2ND FLOOR, BOSTON
Confronta ALLR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.02 | 15.00M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Allarity Therapeutics Inc Borsa (ALLR) Ultime notizie
Allarity Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional
What drives Allarity Therapeutics Inc. stock priceTremendous financial leverage - Autocar Professional
Is Allarity Therapeutics Inc. a good long term investmentMassive stock growth - jammulinksnews.com
How Allarity Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser
What analysts say about Allarity Therapeutics Inc. stockTremendous return rates - Autocar Professional
Will Allarity Therapeutics Inc. stock benefit from interest rate changesFree Stock Investment Growth Plan - beatles.ru
Does Allarity Therapeutics Inc. stock pay reliable dividendsRisk Adjusted Stock Signals - Newser
Allarity Therapeutics Secures New EU Commercial Agreement - TipRanks
Why Allarity Therapeutics Inc. stock attracts strong analyst attentionTop Rated Trade Entries - Newser
What makes Allarity Therapeutics Inc. stock price move sharplyReal Time Stock Signal - Newser
Allarity Therapeutics Announces New Licensing and - GlobeNewswire
Allarity Therapeutics Signs New Precision Oncology Licensing Deal for Breast Cancer | ALLR Stock News - Stock Titan
Allarity Therapeutics appoints Jeff Ervin as CFO - MSN
Jeffrey S. Ervin Appointed as Allarity’s New CFO - The Globe and Mail
Allarity Therapeutics appoints Jeff Ervin as new CFO By Investing.com - Investing.com Nigeria
Allarity Therapeutics, Inc. Announces Chief Financial Officer Changes - MarketScreener
Allarity Therapeutics appoints Jeffrey S. Ervin as part-time chief financial officer - Investing.com Nigeria
Allarity Therapeutics appoints Jeff Ervin as new CFO - Investing.com
Allarity Therapeutics Appoints Jeff Ervin To Succeed Alexander Epshinsky As CFO - Nasdaq
Allarity Therapeutics Appoints Jeff Ervin as New Chief Financial Officer - Nasdaq
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer - GlobeNewswire
Former NYSE Executive Takes CFO Role at Cancer Drug Developer Allarity Therapeutics - Stock Titan
Allarity Therapeutics Secures Australian Patent for DRP® Platform - The Globe and Mail
Allarity Therapeutics Advances Phase 2 Stenoparib Trial - TipRanks
Allarity Therapeutics receives patent acceptance in Australia for cancer diagnostic - Investing.com
Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic - The Manila Times
Allarity Therapeutics Doses Second Patient in Phase 2 Ovarian Cancer Trial - MarketScreener
Allarity Therapeutics Holds Annual Stockholders Meeting - TipRanks
Allarity Therapeutics Stock Nears Yearly Low: A Trader’s High-Risk Analysis - thekhabrilal
Allarity Therapeutics, Inc Announces Changes to Board of Directors - MarketScreener
Allarity Therapeutics appoints pharma veteran Høiland to board - Investing.com India
Allarity Therapeutics Inc Azioni (ALLR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):